Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro

Journal of Cellular Biochemistry

Volumn 113, Issue 4, 2012, Pages 1142-1151

  Buchanan, Cara F ^a   Szot, Christopher S ^a   Wilson, Tia D ^a   Akman, Steven ^b   Metheny Barlow, Linda J ^b   Robertson, John L ^c   Freeman, Joseph W ^a   Rylander, Marissa Nichole ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

ANGIOPOIETIN; TUMORIGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL PH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857584911     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23447     Document Type: Article

References (52)

1. Al-Nadiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R,. 2007. The use of alamar blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22: 1304-1309.
2. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM,. 1998. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83: 233-240.
3. Benndorf R, Boger RH, Ergun S, Steenpass A, Wieland T,. 2003. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 93: 438-447.
4. Bissell MJ, Radisky D,. 2001. Putting tumours in context. Nat Rev Cancer 1: 46-54.
5. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E,. 2001. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93: 309-314.
6. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF,. 1999. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5: 1041-1056.
7. Butler JM, Kobayashi H, Rafii S,. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10: 138-146.
8. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ,. 2007. A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
9. Carmeliet P,. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395.
10. Carmeliet P,. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932-936.
11. Carmeliet P, Jain RK,. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
12. Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MA, Rafii S,. 2000. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 106: 511-521.
13. Djonov V, Andres AC, Ziemiecki A,. 2001. Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech 52: 182-189.
14. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL,. 1993. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 53: 4161-4163.
15. Hanahan D, Folkman J,. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
16. Hashimoto T, Wu Y, Boudreau N, Li J, Matsumoto M, Young W,. 2004. Regulation of tie2 expression by angiopoietinâPotential feedback system. Endothelium 11: 207-210.
17. Hayes AJ, Huang WQ, Mallah J, Yang D, Lippman ME, Li LY,. 1999. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 58: 224-237.
18. Hayes AJ, Huang WQ, Yu J, Maisonpierre PC, Liu A, Kern FG, Lippman ME, McLeskey SW, Li LY,. 2000. Expression and function of angiopoietin-1 in breast cancer. Br J Cancer 83: 1154-1160.
19. Hewett P, Popplewell A, Finney H, Murray JC,. 1999. Changes in microvessel endothelial cell gene expression in an in vitro human breast tumour endothelial cell model. Angiogenesis 3: 221-229.
20. Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, Reboldi A, Favaro E, Mecarozzi M, Di Mario G, Screpanti I, Ponzoni M, Doglioni C, Amadori A,. 2009. Cross-talk between tumor and endothelial cells involving the Notch3-DII4 interaction marks escape from tumor dormancy. Cancer Res 69: 1314-1323.
21. Jones PF,. 2003. Not just angiogenesisâWider roles for the angiopoietins. J Pathol 201: 515-527.
22. Joyce JA,. 2005. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7: 513-520.
23. Jung YD, Ahmad SA, Liu W, Reinmuth N, Parikh A, Stoeltzing O, Fan F, Ellis LM,. 2002. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis. Semin Cancer Biol 12: 105-112.
24. Kaneko T, Zhang Z, Mantellini MG, Karl E, Zeitlin B, Verhaegen M, Soengas MS, Lingen M, Strieter RM, Nunez G, Nor JE,. 2007. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res 67: 9685-9693.
25. Khodarev NN, Yu J, Labay E, Darga T, Brown CK, Mauceri HJ, Yassari R, Gupta N, Weichselbaum RR,. 2003. Tumour-endothelium interactions in co-culture: Coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116: 1013-1022.
26. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY,. 2000a. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res 86: 24-29.
27. Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY,. 2000b. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19: 4549-4552.
28. Korah RM, Sysounthone V, Golowa Y, Wieder R,. 2000. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res 60: 733-740.
29. Lee YW, Eum SY, Chen KC, Hennig B, Toborek M,. 2004. Gene expression profile in interleukin-4-stimulated human vascular endothelial cells. Mol Med 10: 19-27.
30. Li CY, Shan S, Huang Q, Braun RD, Lanzen J, Hu K, Lin P, Dewhirst MW,. 2000. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92: 143-147.
31. Liotta LA, Kohn EC,. 2001. The microenvironment of the tumour-host interface. Nature 411: 375-379.
32. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
33. Lobov IB, Brooks PC, Lang RA,. 2002. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99: 11205-11210.
34. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD,. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
35. Metheny-Barlow LJ, Li LY,. 2003. The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 13: 309-317.
36. Nikitenko LL,. 2009. Vascular endothelium in cancer. Cell Tissue Res 335: 223-240.
37. Park CC, Bissell MJ, Barcellos-Hoff MH,. 2000. The influence of the microenvironment on the malignant phenotype. Mol Med Today 6: 324-329.
38. Pepper MS, Ferrara N, Orci L, Montesano R,. 1992. Potent synergism between vascular endothelial growth-factor and basic fibroblast growth-factor in the induction of angiogenesis invitro. Biochem Biophys Res Commun 189: 824-831.
39. Rudolph MC, McManaman JL, Hunter L, Phang T, Neville MC,. 2003. Functional development of the mammary gland: Use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J Mammary Gland Biol Neoplasia 8: 287-307.
40. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L,. 2001. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: Implications for tumor development and progression. Cancer Res 61: 1320-1326.
41. Shekhar MP, Werdell J, Tait L,. 2000. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: Regulation by estrogen. Cancer Res 60: 439-449.
42. Spector JA, Greenwald JA, Warren SM, Bouletreau PJ, Crisera FE, Mehrara BJ, Longaker MT,. 2002. Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast Reconstr Surg 109: 631-642; discussion 643-644.
43. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R,. 2005. Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 102: 18111-18116.
44. Tait CR, Jones PF,. 2004. Angiopoietins in tumours: The angiogenic switch. J Pathol 204: 1-10.
45. Tlsty TD,. 2001. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 11: 97-104.
46. Tsai JC, Goldman CK, Gillespie GY,. 1995. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82: 864-873.
47. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G,. 2002. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 109: 777-785.
48. Warner KA, Miyazawa M, Cordeiro MM, Love WJ, Pinsky MS, Neiva KG, Spalding AC, Nor JE,. 2008. Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. Neoplasia 10: 131-139.
49. Wernert N,. 1997. The multiple roles of tumour stroma. Virchows Arch 430: 433-443.
50. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM,. 1998. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273: 18514-18521.
51. Zeng QH, Li SL, Chepeha DB, Giordano TJ, Li J, Zhang HL, Polverini PJ, Nor J, Kitajewski J, Wang CY,. 2005. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8: 13-23.
52. Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G,. 2003. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63: 3403-3412.